Clinical assessment of glybenclamide (daonil) in diabetes mellitus.
D002747:Chlorpropamide / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D005905:Glyburide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D014044:Tolbutamide / Q000627:therapeutic use
D014044:Tolbutamide; D005905:Glyburide; D002747:Chlorpropamide